ERFA HQ 4% Gel (2019-07-03) Jul 3, 2019 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
ERFA HQ 4% Gel
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength M231, P027 Recalling Firm ERFA Canada 2012 Inc. 8250 Decarie, Suite 110 Montreal H4P 2P5 Quebec CANADA Marketing Authorization Holder ERFA Canada 2012 Inc. 8250 Decarie, Suite 110 Montreal H4P 2P5 Quebec CANADA ERFA HQ 4% Gel Gel NPN 80068828 Hydroquinone 4.0 % (w/w)
As of June 30, 2019, products containing hydroquinone greater than 2% will require a prescription from a healthcare practitioner to be sold in Canada and valid market authorization.